Connor, Clark & Lunn Investment Management (CC&L)’s Clearside Biomedical CLSD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,408
| Closed | -$38.9K | – | 1420 |
|
|
2024
Q1 | $38.9K | Buy |
+25,408
| New | +$38.9K | ﹤0.01% | 1490 |
|
|
2023
Q3 | – | Sell |
-15,562
| Closed | -$17.4K | – | 1386 |
|
|
2023
Q2 | $17.4K | Sell |
15,562
-38,234
| -71% | -$42.8K | ﹤0.01% | 1286 |
|
|
2023
Q1 | $55.9K | Sell |
53,796
-3,238
| -6% | -$3.37K | ﹤0.01% | 1187 |
|
|
2022
Q4 | $63.9K | Sell |
57,034
-10,136
| -15% | -$11.4K | ﹤0.01% | 1142 |
|
|
2022
Q3 | $76K | Buy |
67,170
+17,141
| +34% | +$19.4K | ﹤0.01% | 1050 |
|
|
2022
Q2 | $74K | Sell |
50,029
-29,223
| -37% | -$43.2K | ﹤0.01% | 1000 |
|
|
2022
Q1 | $181K | Buy |
+79,252
| New | +$181K | ﹤0.01% | 951 |
|